MEDS vs YI
Loading...
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDS is a Hold and YI is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MEDS’s FA Score shows that 0 FA rating(s) are green whileYI’s FA Score has 0 green FA rating(s).
- MEDS’s FA Score: 0 green, 5 red.
- YI’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MEDS’s TA Score shows that 5 TA indicator(s) are bullish while YI’s TA Score has 6 bullish TA indicator(s).
- MEDS’s TA Score: 5 bullish, 4 bearish.
- YI’s TA Score: 6 bullish, 4 bearish.
Price Growth
MEDS (@Drugstore Chains) experienced а -5.83% price change this week, while YI (@Medical Distributors) price change was +15.04% for the same time period.
The average weekly price growth across all stocks in the @Drugstore Chains industry was -2.79%. For the same industry, the average monthly price growth was -0.33%, and the average quarterly price growth was -1.69%.
The average weekly price growth across all stocks in the @Medical Distributors industry was +10.65%. For the same industry, the average monthly price growth was +1.11%, and the average quarterly price growth was +12.56%.
Reported Earning Dates
MEDS is expected to report earnings on Jul 24, 2023.
YI is expected to report earnings on May 23, 2024.
Industries' Descriptions
@Drugstore Chains (-2.79% weekly)The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.
@Medical Distributors (+10.65% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
| MEDS | YI | MEDS / YI | |
| Capitalization | 12.3M | 97.4M | 13% |
| EBITDA | -2.68M | -238.88M | 1% |
| Gain YTD | 51.858 | -16.129 | -322% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 10.5M | 14.7B | 0% |
| Total Cash | 34K | 699M | 0% |
| Total Debt | 6.48M | 398M | 2% |
MEDS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 2 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 98 | |
PRICE GROWTH RATING 1..100 | 40 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | 95 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| MEDS | YI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 78% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 87% | 1 day ago 88% |
| Momentum ODDS (%) | N/A | 1 day ago 82% |
| MACD ODDS (%) | 1 day ago 78% | 1 day ago 69% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 88% | 1 day ago 78% |
| Advances ODDS (%) | 1 day ago 81% | 3 days ago 77% |
| Declines ODDS (%) | 2 days ago 90% | 22 days ago 88% |
| BollingerBands ODDS (%) | 4 days ago 90% | 1 day ago 88% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 82% |
MEDS and
Correlation & Price change
A.I.dvisor tells us that MEDS and LFMD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEDS and LFMD's prices will move in lockstep.
| Ticker / NAME | Correlation To MEDS | 1D Price Change % | ||
|---|---|---|---|---|
| MEDS | 100% | +0.86% | ||
| LFMD - MEDS | 22% Poorly correlated | -8.48% | ||
| PETS - MEDS | 7% Poorly correlated | -6.31% | ||
| LFLY - MEDS | 5% Poorly correlated | +3.87% | ||
| SSY - MEDS | 4% Poorly correlated | +1.61% | ||
| YI - MEDS | 4% Poorly correlated | -1.14% | ||
More | ||||
YI and
Correlation & Price change
A.I.dvisor tells us that YI and LFMD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YI and LFMD's prices will move in lockstep.